Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
US8962692B2 · kind B2 · utility
4Cited by
1References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 7, 2012 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | May 7, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses cysteine prodrugs having the general formula:cystine dimers of the cysteine prodrugs having the general formula:protected cysteine analogs having the general formula:and dimers of the protected cysteine analogs having the general formula:The invention further encompasses pharmaceutical compositions containing the disclosed prodrugs, dimers, and analogs, and methods of using such compounds for treatment of schizophrenia and drug addiction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.